BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Radosevich JJ, Patanwala AE, Erstad BL. Hepatotoxicity in Obese Versus Nonobese Patients With Acetaminophen Poisoning Who Are Treated With Intravenous N-Acetylcysteine. Am J Ther 2016;23:e714-9. [PMID: 24263163 DOI: 10.1097/01.mjt.0000434043.62372.00] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Licata A, Minissale MG, Stankevičiūtė S, Sanabria-cabrera J, Lucena MI, Andrade RJ, Almasio PL. N-Acetylcysteine for Preventing Acetaminophen-Induced Liver Injury: A Comprehensive Review. Front Pharmacol 2022;13:828565. [DOI: 10.3389/fphar.2022.828565] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Louvet A, Mathurin P. REPLY. Hepatology 2021;74:2904-5. [PMID: 33638872 DOI: 10.1002/hep.31769] [Reference Citation Analysis]
3 Baum RA, Woolum JA, Bailey AM, Howell MM, Weant KA, Geraghty L, Mohan S, Webb AN, Su MK, Akpunonu P; Collaborators. Evaluation of Dosing Strategies of N-acetylcysteine for Acetaminophen Toxicity in Patients Greater than 100 Kilograms: Should the Dosage Cap Be Used? J Med Toxicol 2021;17:241-9. [PMID: 33884558 DOI: 10.1007/s13181-021-00822-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
4 García-Román R, Francés R. Acetaminophen-Induced Liver Damage in Hepatic Steatosis. Clin Pharmacol Ther 2020;107:1068-81. [PMID: 31638270 DOI: 10.1002/cpt.1701] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
5 Chrøis KM, Larsen S, Pedersen JS, Rygg MO, Boilsen AEB, Bendtsen F, Dela F. Acetaminophen toxicity induces mitochondrial complex I inhibition in human liver tissue. Basic Clin Pharmacol Toxicol 2019;126:86-91. [DOI: 10.1111/bcpt.13304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Castanares-Zapatero D, Dinant V, Ruggiano I, Willem H, Laterre PF, Hantson P. Pattern of Paracetamol Poisoning: Influence on Outcome and Complications. Toxics 2018;6:E58. [PMID: 30274302 DOI: 10.3390/toxics6040058] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
7 Chomchai S, Chomchai C. Being overweight or obese as a risk factor for acute liver injury secondary to acute acetaminophen overdose. Pharmacoepidemiol Drug Saf 2018;27:19-24. [DOI: 10.1002/pds.4339] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
8 Massart J, Begriche K, Moreau C, Fromenty B. Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity. J Clin Transl Res 2017;3:212-32. [PMID: 28691103 DOI: 10.18053/jctres.03.2017S1.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 40] [Article Influence: 2.0] [Reference Citation Analysis]
9 Hayward KL, Powell EE, Irvine KM, Martin JH. Can paracetamol (acetaminophen) be administered to patients with liver impairment? Br J Clin Pharmacol. 2016;81:210-222. [PMID: 26460177 DOI: 10.1111/bcp.12802] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 6.3] [Reference Citation Analysis]
10 Michaut A, Moreau C, Robin MA, Fromenty B. Acetaminophen-induced liver injury in obesity and nonalcoholic fatty liver disease. Liver Int 2014;34:e171-9. [PMID: 24575957 DOI: 10.1111/liv.12514] [Cited by in Crossref: 78] [Cited by in F6Publishing: 79] [Article Influence: 9.8] [Reference Citation Analysis]